| 0 (0%) | 12-26 19:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 8.17 | 1-year : | 8.3 |
| Resists | First : | 7 | Second : | 7.11 |
| Pivot price | 6.94  |
|||
| Supports | First : | 6.82 | Second : | 5.68 |
| MAs | MA(5) : | 6.87 |
MA(20) : | 6.94 |
| MA(100) : | 7.04 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 2.4 |
D(3) : | 9.4 |
| RSI | RSI(14): 37.3 |
|||
| 52-week | High : | 7.82 | Low : | 6.61 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MHF ] has closed above bottom band by 4.4%. Bollinger Bands are 33.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.89 - 6.92 | 6.92 - 6.95 |
| Low: | 6.73 - 6.78 | 6.78 - 6.82 |
| Close: | 6.76 - 6.84 | 6.84 - 6.89 |
Sun, 21 Dec 2025
Discipline and Rules-Based Execution in MHF Response - Stock Traders Daily
Wed, 17 Dec 2025
A Significant Milestone in the Progress of the TarGeT trial - MHF Centre for Brain Cancer Research - Oncodaily
Mon, 08 Dec 2025
MHF Welcomes Psychiatrist Dr. Delia Deoagnes Monier Herrera to its Clinical Team - SMN News
Tue, 28 Oct 2025
Celebrating Cassandra Griffin’s PhD and Dedication to the MHF Biobank - MHF Centre for Brain Cancer Research - Oncodaily
Thu, 23 Oct 2025
BPS backs MHF's calls to end Scotland’s public mental health emergency - British Psychological Society
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 22 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 26.8 (%) |
| Shares Short | 36 (K) |
| Shares Short P.Month | 47 (K) |
| EPS | 0.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.92 |
| Profit Margin | 41.1 % |
| Operating Margin | 83.1 % |
| Return on Assets (ttm) | 2.2 % |
| Return on Equity (ttm) | 1.8 % |
| Qtrly Rev. Growth | -3.3 % |
| Gross Profit (p.s.) | 0.3 |
| Sales Per Share | 0.3 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 52.53 |
| PEG Ratio | 0 |
| Price to Book value | 0.98 |
| Price to Sales | 22.07 |
| Price to Cash Flow | 0 |
| Dividend | 0.02 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|